by Shana Cristoferi | Jul 16, 2020 | IMV Inc., News
Watch here IMV’s CEO, Frederic Ors, was interviewed by CTV Montreal, providing more details about the IMV’s COVID-19 vaccine candidate and unique delivery platform, DPX.
by Shana Cristoferi | Jul 14, 2020 | IMV Inc., News
Watch here A Nova Scotia laboratory working on a vaccine for COVID-19 has been given the green light from Health Canada to proceed with its plan for human trials. “The clinical team is putting together the final documents for Health Canada final approval, to...
by Shana Cristoferi | May 15, 2020 | IMV Inc., News
Read original here IMV Inc., a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines against infectious diseases, today announced financial results for the first quarter ended March 31, 2020 and provided an update on...
by Shana Cristoferi | May 7, 2020 | IMV Inc., News
Read original here IMV Inc. a clinical-stage biopharmaceutical company pioneering a novel class of cancer immunotherapies and vaccines to fight against infectious diseases including COVID-19, today announced that it has completed its previously announced non-brokered...
by Shana Cristoferi | Apr 30, 2020 | IMV Inc., News
Watch here BioNova Member IMV Inc. will begin the first round of human trials for their COVID-19 vaccine this summer. The Maritime lab had a head start in the vaccine development process, building on a vaccine it developed to combat a different respiratory...
by Shana Cristoferi | Apr 28, 2020 | IMV Inc., News, Spring Loaded Technology
Read original here From producing protective equipment and hand sanitizer, to innovating medical technology, here’s how some Nova Scotia companies are changing the way they do business. In response to COVID-19, IMV initiated the development of a vaccine. The...
